Variable Total Study Population Patients free from ATAs Patients with ATA recurrence Statistical Significance
Number of Patients (% of Total Population)
174
76% (114/150)
24% (36/150)
Mean Age (\(\pm\)SD)
60.1 years (\(\pm\)10.1) (n = 174) 59.7 years (\(\pm\)9.8) (n = 114) 61.9 years (\(\pm\)11.0) (n = 36)
p = 0.2626*
% Male Sex
72% (126/174) 72% (82/114) 69% (25/36)
p = 0.7737†
% White Race 100% (174/174)
% Mean BMI (\(\pm\)SD)
32.0 (\(\pm\)6.8) (n = 174) 31.9 (\(\pm\)6.8) (n=114) 32.1 (\(\pm\)8.0) (n=36)
p = 0.8706*
% with BMI ≥30
59% (102/174) 59% (67/114) 56% (20/36)
p = 0.7332†
% with HLD
55% (95/174) 55% (63/114) 61% (22/36)
p = 0.5370†
% with PVD
5% (9/174) 4% (5/114) 11% (4/36)
p = 0.2191‡
% with prior CVA
14% (23/161)
14% (17/125)
17% (3/36)
p = 0.6431†
% with CHA2DS2-VASc ≥ 2
77% (134/174) 76% (87/114) 75% (27/36)
p = 0.8720†
% with HTN
67% (116/174) 65% (74/114) 69% (25/36)
p = 0.6168†
% Ever Smokers
36% (62/174) 33% (38/114) 44% (16/36)
p = 0.2260†
% with Chronic Lung Disease
10% (17/174) 9% (10/114) 14% (5/36)
p = 0.3556‡
% with DM
14% (25/174) 14% (16/114) 14% (5/36)
p = 0.9824†
% with Renal Failure
0% (0/174)